A review of disease activity measures for psoriatic arthritis: what is the best approach?

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

(2014) Christopher Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

(2014) Arthur Kavanaugh et al.   ANNALS OF THE RHEUMATIC DISEASES

Composite Disease Activity and Responder Indices for Psoriatic Arthritis: A Report from the GRAPPA 2013 Meeting on Development of Cutoffs for Both Disease Activity States and Response

(2014) P. S. Helliwell et al.   JOURNAL OF RHEUMATOLOGY

Development of a Disease Activity and Responder Index for Psoriatic Arthritis -- Report of the Psoriatic Arthritis Module at OMERACT 11

(2014) L. C. Coates et al.   JOURNAL OF RHEUMATOLOGY

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

(2013) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Brief Report: Reduced Joint Counts Misclassify Patients With Oligoarticular Psoriatic Arthritis and Miss Significant Numbers of Patients With Active Disease

(2013) Laura C. Coates et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

(2013) Iain B McInnes et al.   LANCET

Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab

(2013) Philip S. Helliwell et al.   ARTHRITIS CARE & RESEARCH

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

(2012) Philip S Helliwell et al.   ANNALS OF THE RHEUMATIC DISEASES

MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis

(2012) Laura C. Coates et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Patient-reported outcomes in rheumatoid arthritis

(2012) Minyoung Her et al.   CURRENT OPINION IN RHEUMATOLOGY

Development of Composite Measures for Psoriatic Arthritis: A Report from the GRAPPA 2010 Annual Meeting

(2012) P. S. HELLIWELL et al.   JOURNAL OF RHEUMATOLOGY

Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set

(2011) Oliver FitzGerald et al.   ANNALS OF THE RHEUMATIC DISEASES

The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) Is Reliable and Sensitive to Change: Results from an OMERACT Workshop

(2011) P. BOYESEN et al.   JOURNAL OF RHEUMATOLOGY

Development of a Disease Severity and Responder Index for Psoriatic Arthritis (PsA) -- Report of the OMERACT 10 PsA Special Interest Group

(2011) L. C. COATES et al.   JOURNAL OF RHEUMATOLOGY

Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study

(2011) ALBERTO CAULI et al.   JOURNAL OF RHEUMATOLOGY

Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesit

(2011) Philip J. Mease   ARTHRITIS CARE & RESEARCH

Development of a preliminary composite disease activity index in psoriatic arthritis

(2010) A. Mumtaz et al.   ANNALS OF THE RHEUMATIC DISEASES

Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?

(2010) L. Eder et al.   ANNALS OF THE RHEUMATIC DISEASES

Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis

(2010) M. Schoels et al.   ANNALS OF THE RHEUMATIC DISEASES

Disease measurement – enthesitis, skin, nails, spine and dactylitis

(2010) Laura C. Coates et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Methods of Outcomes Measurement in Nail Psoriasis

(2010) M. Augustin et al.   DERMATOLOGY

Informing Response Criteria for Psoriatic Arthritis. I: Discrimination Models Based on Data from 3 Anti-Tumor Necrosis Factor Randomized Studies

(2010) D. D. GLADMAN et al.   JOURNAL OF RHEUMATOLOGY

Informing Response Criteria for Psoriatic Arthritis (PsA). II: Further Considerations and a Proposal -- The PsA Joint Activity Index

(2010) D. D. GLADMAN et al.   JOURNAL OF RHEUMATOLOGY

Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

(2010) Laura C. Coates et al.   ARTHRITIS CARE & RESEARCH

Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

(2009) L C Coates et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis

(2009) V. P. Nell-Duxneuner et al.   ANNALS OF THE RHEUMATIC DISEASES

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

(2009) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System (PsAMRIS): Definitions of Key Pathologies, Suggested MRI Sequences, and Preliminary Scoring System for PsA Hands

(2009) M. OSTERGAARD et al.   JOURNAL OF RHEUMATOLOGY

Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis

(2009) José Luis Fernández-Sueiro et al.   ARTHRITIS CARE & RESEARCH

Occurrence and correlates of fatigue in psoriatic arthritis

(2008) J A Husted et al.   ANNALS OF THE RHEUMATIC DISEASES

Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index

(2008) W P Maksymowych et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment recommendations for psoriatic arthritis

(2008) C T Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

Validity of enthesis ultrasound assessment in spondyloarthropathy

(2008) E de Miguel et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

(2008) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Measuring clinical enthesitis in psoriatic arthritis: Assessment of existing measures and development of an instrument specific to psoriatic arthritis

(2008) Paul J. Healy et al.   ARTHRITIS AND RHEUMATISM

A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index

(2008) J. Berth-Jones et al.   BRITISH JOURNAL OF DERMATOLOGY